NVE Corporation (NVEC) - 10-K Summary
Business Context and Reporting Period
Company: NVE Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: March 31, 2011
Business Overview: NVE develops and sells spintronic devices (sensors, couplers, and MRAM technology) used to acquire, store, and transmit information. The company operates in one reportable segment, serving markets in factory automation, medical devices, and industrial control. It also engages in contract research and development, primarily with U.S. Government agencies.
Key Financial Metrics
| Metric | Fiscal 2011 | Fiscal 2010 | Change |
|---|---|---|---|
| Total Revenue | $31,197,063 | $28,147,185 | +10.8% |
| Product Sales | $26,024,823 | $22,665,860 | +14.8% |
| Contract R&D Revenue | $5,172,240 | $5,481,325 | -5.6% |
| Gross Profit | $21,413,365 | $19,834,170 | +8.0% |
| Gross Margin | 68.6% | 70.5% | -1.9 pts |
| Net Income | $13,360,945 | $11,999,344 | +11.3% |
| Diluted EPS | $2.76 | $2.47 | +11.7% |
| Cash & Marketable Securities | $62,179,707 | $49,543,766 | +25.5% |
| Total Assets | $71,836,225 | $57,462,914 | +25.0% |
| Operating Cash Flow | $12,808,807 | $12,463,616 | +2.8% |
Debt & Liquidity: The company reported no long-term debt. Total current liabilities were $1,865,676. The company maintains a strong liquidity position with cash and marketable securities representing approximately 85% of total assets.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 11% driven by a 15% increase in product sales, partially offset by a 6% decline in contract R&D revenue due to the completion of certain contracts.
- Geographic Shift: International sales accounted for 55% of revenue in 2011 (up from 49% in 2010). Revenue increased 29% in Europe and 11% in Asia, while U.S. revenue decreased slightly by 1%.
- Margin Compression: Gross margin decreased from 70.5% to 68.6% due to a less favorable product sales mix.
- Interest Income: Interest and other income increased 25% to $2.02 million, driven by higher yields on the company's substantial portfolio of marketable securities.
- Backlog: Firm contract R&D backlog increased to $2.96 million from $1.53 million, with approximately 51% attributable to U.S. Government agencies.
Outlook, Risks, and Management Commentary
Management Commentary: Management attributes growth to new customers and increased volume from existing customers in industrial control and factory automation. The company plans to broaden sensor and coupler lines and target consumer electronics markets long-term. They intend to retain earnings for business expansion and IP defense rather than paying dividends.
Risks and Contingencies:
- Customer Concentration: Reliance on large customers including Avago Technologies, Phonak AG, St. Jude Medical, and the U.S. Government. Loss of any major customer could materially impact revenue.
- Supply Chain: Dependence on single-source suppliers for critical wafers and packaging (specifically Circuit Electronic Industries in Thailand, which is under voluntary debt rehabilitation).
- Government Funding: While government revenue is less than 10% of total, the company relies on SBIR contracts for R&D. Changes in government spending priorities could impact future R&D progress.
- Market Risk: Approximately 85% of assets are held in marketable securities. Downgrades or defaults in these securities could materially impact financial condition.
- Product Liability: Sensors used in medical devices expose the company to potential liability claims, though indemnification agreements exist.
Investor Verification Checklist
- Customer Concentration: Verify the stability of relationships with top customers (Avago, Phonak, St. Jude) and the impact of their specific market conditions.
- Supply Chain Resilience: Assess the risk associated with the single-source packaging vendor (CEI) in Thailand and the availability of critical wafer supplies.
- Investment Portfolio Quality: Review the credit ratings and maturity profile of the $61.2 million marketable securities portfolio, noting the $157k in unrealized losses.
- Government Contract Renewals: Monitor the status of the $2.96 million firm backlog, particularly the 51% portion from U.S. Government agencies, to ensure follow-on funding.
- MRAM Licensing: Evaluate the status of negotiations with Freescale/EverSpin regarding MRAM licensing, as this represents a potential long-term revenue stream.